These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31746818)

  • 1. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.
    Naples JG; Ruckenstein MJ; Singh J; Cox BC; Li D
    Otol Neurotol; 2020 Jan; 41(1):115-122. PubMed ID: 31746818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
    Naples JG; Parham K
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):144-9. PubMed ID: 26419839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prestin as an Otologic Biomarker of Cisplatin Ototoxicity in a Guinea Pig Model.
    Naples J; Cox R; Bonaiuto G; Parham K
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):541-546. PubMed ID: 29160156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
    Hughes AL; Hussain N; Pafford R; Parham K
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW; Morest DK; Parham K
    Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 2 Different Intratympanic Steroid Regimen on Prevention of Cisplatin Ototoxicity: An Experimental Study.
    Taş BM; Şimşek G; Azman M; Kılıç R
    Ear Nose Throat J; 2021 Jul; 100(6):417-422. PubMed ID: 31569969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
    Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
    Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
    Rybak LP; Husain K; Whitworth C; Somani SM
    Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Protective Effect of Platelet Rich Plasma Against Cisplatin-Induced Ototoxicity.
    Yurtsever KN; Baklaci D; Guler I; Kuzucu I; Kum RO; Ozhamam EU; Ozcan M; Dere H
    J Craniofac Surg; 2020; 31(5):e506-e509. PubMed ID: 32541270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
    Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating transcription factor 6 contributes to cisplatin‑induced ototoxicity via regulating the unfolded proteins response.
    Liu YC; Bai X; Liao B; Chen XB; Li LH; Liu YH; Hu HJ; Xu K
    Biomed Pharmacother; 2024 Aug; 177():117025. PubMed ID: 38941893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
    Simsek G; Taş BM; Muluk NB; Azman M; Kılıç R
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study.
    Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND
    J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
    Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
    Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
    Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
    Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
    Li Y; Ding D; Jiang H; Fu Y; Salvi R
    Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?
    Saliba I; El Fata F
    Neurotox Res; 2012 Apr; 21(3):302-8. PubMed ID: 21989624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.